Literature DB >> 17551066

Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer.

S Seewald1, T L Ang, N Soehendra.   

Abstract

Barrett's oesophagus is premalignant. Oesophagectomy is traditionally regarded as the standard treatment option in the presence of high grade intraepithelial neoplasia or intramucosal cancer. However, oesophagectomy is associated with high rates of mortality and morbidity. Endoscopic ablative therapies are limited by the lack of tissue for histological assessment, and the ablation may be incomplete. Endoscopic mucosal resection is an alternative to surgery in the management of high grade intraepithelial neoplasia and intramucosal cancer. It is less invasive than surgery and, unlike ablative treatments, provides tissue for histological assessment. This review will cover the indications, techniques and results of endoscopic mucosal resection.

Entities:  

Mesh:

Year:  2007        PMID: 17551066      PMCID: PMC2600047          DOI: 10.1136/pgmj.2006.054841

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  47 in total

1.  Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.

Authors:  J L Van Laethem; R Jagodzinski; M O Peny; M Cremer; J Devière
Journal:  Endoscopy       Date:  2001-03       Impact factor: 10.093

2.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

3.  High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series.

Authors:  Irving Waxman; Gottumukkala S Raju; Jonathan Critchlow; Donald A Antonioli; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2006-06-16       Impact factor: 10.864

4.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.

Authors:  M Kahaleh; J-L Van Laethem; N Nagy; M Cremer; J Devière
Journal:  Endoscopy       Date:  2002-12       Impact factor: 10.093

6.  Endoscopic submucosal dissection of early esophageal cancer.

Authors:  Tsuneo Oyama; Akihisa Tomori; Kinichi Hotta; Syuko Morita; Ken Kominato; Masaki Tanaka; Yoshinori Miyata
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

7.  Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions.

Authors:  H Inoue; K Takeshita; H Hori; Y Muraoka; H Yoneshima; M Endo
Journal:  Gastrointest Endosc       Date:  1993 Jan-Feb       Impact factor: 9.427

8.  Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.

Authors:  A Csendes; G Smok; P Burdiles; F Quesada; C Huertas; J Rojas; O Korn
Journal:  Dis Esophagus       Date:  2000       Impact factor: 3.429

9.  Limited resection for early adenocarcinoma in Barrett's esophagus.

Authors:  H J Stein; M Feith; J Mueller; M Werner; J R Siewert
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

10.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

View more
  8 in total

1.  Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma.

Authors:  Yasser M Bhat; Emma E Furth; Colleen M Brensinger; Gregory G Ginsberg
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 2.  Management of high-grade dysplasia.

Authors:  Francesco Palazzo; Piero M Fisichella; Marco G Patti
Journal:  Curr Gastroenterol Rep       Date:  2008-06

3.  Endoluminal resection and tissue acquisition.

Authors:  Tiing Leong Ang; Stefan Seewald
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

Review 4.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

5.  Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation.

Authors:  Melina C Vassiliou; Daniel von Renteln; Daniel C Wiener; Stuart R Gordon; Richard I Rothstein
Journal:  Surg Endosc       Date:  2009-08-27       Impact factor: 4.584

Review 6.  Management of Barrett's esophageal carcinoma.

Authors:  Tatsuya Miyazaki; Takanori Inose; Naritaka Tanaka; Takehiko Yokobori; Shigemasa Suzuki; Daigo Ozawa; Makoto Sohda; Masanobu Nakajima; Minoru Fukuchi; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2013-01-03       Impact factor: 2.549

Review 7.  Endoscopic mucosal resection in the upper gastrointestinal tract.

Authors:  Anis Ahmadi; Peter Draganov
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

8.  Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett's Esophagus and Related Superficial Lesions.

Authors:  Hany M Elsadek; Mamdouh M Radwan
Journal:  Int Sch Res Notices       Date:  2015-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.